Coronaviruses are patented (and you can’t patent anything from nature).

Only items that have been created by man may be patented. This was solidified in a Supreme Court ruling in the case Mayo v. Prometheus in 2012. (Source, Source)

“Q: What Cannot Be Patented? Can I Patent a Living Thing? A: It depends. If your invention is a product of nature, it falls under excluded subject matter. However, if your invention does not occur naturally and can only exist through some work on your part, you may be able to get a patent. For example:
- You cannot patent a species of mouse that you find running around your laboratory
- You can patent a genetically engineered mouse that you designed for use in cancer research
- You cannot patent a combination of bacteria with beneficial properties if that combination occurs somewhere in nature
- You can patent a species of bacteria that you genetically alter to solve a common problem if that form does not occur naturally Legal Match

Timeline

2003: Coronavirus isolated from humans
2003: SARS
2003: “April 28, 2003, the U.S. Centers for Disease Control and Prevention filed a patent on the genome of the SARS coronavirus. Five days later, Sequoia Pharmaceuticals received a $935,000 grant and filed U.S. Patent 7151163 for a treatment for that same virus.” Source
2003: ““Dana Farber had a monoclonal antibody patent system that came out of three NIH grants. Their patent 7750123 on the monoclonal antibody for SARS-Cov treatment took place in 2003.” Source
2009: LONG CIRCULATING NANOPARTICLES filed on Oct. 6, 2009, provisional application No. FOR SUSTAINED RELEASE OF 61/260,200, filed on Nov. 11, 2009. THERAPEUTICAGENTS A patent for the same thing appears to have been filed in July of 2020: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF SECRETED PROTEINS
2012: Moderna filed their patent for their mRNA vaccine in 2012, extended it in 2015 and then extended it again in 2020. US Patent US 10,703,789 B2
2014: Live, attenuated coronavirus “The coronavirus may be used as a vaccine for treating and/or preventing a disease, such as infectious bronchitis, in a subject.”
2014: Coronavirus
2015: Look at this patent, taken out by Richard A. Rothschild: System and Method for Testing for COVID-19. Now notice the date on the patent: October 13, 2015. In case the link does not work, look up US Patent: US20200279585A1.
2015: “In 2015, a patent was filed by The Pirbright Institute for the live, attenuated coronavirus. The application claims that the new virus could be used to create a vaccine for treating or preventing respiratory viruses. The patent was awarded in 2018. Now, The Pirbright Institute is funded by the UK Department for Environment, Food, and Rural Affairs, the WHO, and the Bill and Melinda Gates Foundation. All of these entities have been loud supporters of mandatory vaccinations and more government control based on “health concerns.” Source
2016: Study: SARS-like WIV1-CoV poised for human emergence
2018: Moderna’s First patent: COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS
2018: Moderna MODIFIED NUCLEOSIDES , NUCLEOTIDES , AND NUCLEIC ACIDS , AND USES THEREOF
2019: Moderna COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS
2019: Moderna COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS
2020: Moderna MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF SECRETED PROTEINS
2020: Moderna ( 54 ) BETACORONAVIRUS MRNA VACCINE ( 58 ) Field of Classification Search
2020: MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF SECRETED PROTEINS